BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17535549)

  • 1. p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques.
    Stark AM; Hugo HH; Tscheslog H; Mehdorn HM
    Neurol Res; 2007 Jul; 29(5):435-40. PubMed ID: 17535549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation.
    Stark AM; Pfannenschmidt S; Tscheslog H; Maass N; Rösel F; Mehdorn HM; Held-Feindt J
    Neurol Res; 2006 Dec; 28(8):787-93. PubMed ID: 17288732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
    Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC
    Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preliminary estimation of bcl-2, bcl-X(L) and p53 genes expression in locally advanced non-small cell lung cancer.
    Karczmarek-Borowska B; Filip A; Zdunek M; Korobowicz E; Wojcierowski J; Korszeń-Pilecka I; Furmanik F
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):124-31. PubMed ID: 15314971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of compound Rhizoma Smilacinus granules on the expression of Bcl-2 and Bax gene in A549 cell lines of non-small cell lung cancers].
    Li GC; Dong KL; Hu CH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):312-5. PubMed ID: 17478943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer.
    Lasithiotaki I; Antoniou KM; Derdas SP; Sarchianaki E; Symvoulakis EK; Psaraki A; Spandidos DA; Stathopoulos EN; Siafakas NM; Sourvinos G
    Int J Cancer; 2013 Aug; 133(3):604-11. PubMed ID: 23355004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.
    Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S
    J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
    Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
    Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers.
    Hanaoka T; Nakayama J; Haniuda M; Sato TA
    Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL-2, BAX and P53 expression profiles in endometrial carcinoma as studied by real-time PCR and immunohistochemistry.
    Porichi O; Nikolaidou ME; Apostolaki A; Tserkezoglou A; Arnogiannaki N; Kassanos D; Margaritis L; Panotopoulou E
    Anticancer Res; 2009 Oct; 29(10):3977-82. PubMed ID: 19846939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
    He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S
    Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
    Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
    Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
    Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.